← Return to FDA approves Rinvoq (Upadacitinib) for GCA

Discussion
Mike avatar

FDA approves Rinvoq (Upadacitinib) for GCA

Polymyalgia Rheumatica (PMR) | Last Active: Oct 3 2:35pm | Replies (16)
Comment receiving replies
Profile picture for asa @asa

Transitioning from Actemra to Rinvoq — Seeking Your Experience

My rheumatologist has decided to transition me from Actemra to Rinvoq. If you're currently taking Rinvoq, I’d really appreciate if you would reply to this thread and tell us. When did you start?
How has it worked for you?
Are you satisfied with the results?

Feel free to share as much or as little as you’d like—any insights are welcome.

Thanks, @asa

Jump to this post

Replies to "Transitioning from Actemra to Rinvoq — Seeking Your Experience My rheumatologist has decided to transition me..."
Mike | @dadcue | Oct 2 9:30pm

@asa

I wish that I could answer your questions ... sorry, but I haven't transitioned from Actemra to Rinvoq.

Transitioning from one biologic to another biologice is common practice for other autoimmune disorders. I don't know why PMR/GCA would be any different. Unlike other autoimmune conditions, current evidence does not outline a standardized approach for switching from one biologic to another for PMR/GCA.

Rinvoq is the next logical choice in my opinion. I might not be too far behind you. I have been on Actemra for 6 years. I don't think Actemra is working as well now as it has for the last 6 years.

I somewhat feel like Actemra is becoming less effective but my rheumatologist warned me that could happen. I hope you can share with us what happened that made you contemplate switching to Rinvoq.

VIEW AND REPLY